Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening

Statistical Methods in Medical Research

Volumn 19, Issue 5, 2010, Pages 507-527

  Weedon Fekjær, Harald ^a   Tretli, Steinar ^a,b   Aalen, Odd O ^c  

^a Cancer Registry of Norway ^*  (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS; STATISTICAL MODEL; STUDY DESIGN; TUMOR GROWTH; TUMOR VOLUME;

DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MARKOV CHAINS; MODELS, STATISTICAL; NEOPLASMS; NORWAY; PROBABILITY; SENSITIVITY AND SPECIFICITY;

EID: 77957780953     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280209359860     Document Type: Review

References (29)

1. Hakama M., Auvinen A., Day NE, Miller AB Sensitivity in cancer screening. Journal of Medical Screening 2007 ; 14: 174-177.
2. Spratt JA, von Fournier D., Spratt JS, Weber EE Decelerating growth and human breast cancer. Cancer 1993 ; 71: 2013-2019.
3. Peer PG, van Dijck JA, Hendriks JH, Holland R., Verbeek AL Age-dependent growth rate of primary breast cancer. Cancer 1993 ; 71: 3547-3551.
4. Spratt JS, Meyer JS, Spratt JA Rates of growth of human solid neoplasms: Part I. Journal of Surgical Oncology 1995 ; 60: 137-146.
5. Spratt JS, Meyer JS, Spratt JA Rates of growth of human neoplasms: Part II. Journal of Surgical Oncology 1996 ; 61: 68-83.
6. Habbema JD, van Oortmarssen GJ, Lubbe JT, van der Maas PJ The MISCAN simulation program for the evaluation of screening for disease. Computer Methods Programs Biomedicine 1985 ; 20: 79-93.
7. van Oortmarssen GJ, Habbema JD, van der Maas PJ, et al. A model for breast cancer screening. Cancer 1990 ; 66: 1601-1612.
8. Day NE, Walter SD Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984 ; 40: 1-14.
9. Duffy SW, Chen HH, Prevost TC, Tabár L. Markov chain models of breast tumour progression and its arrest by screening. In Duffy SW, Hill C, Esteve J, eds. Quantitative methods for the evaluation of cancer screening. Arnold, London ; 2001: 42-60.
10. Duffy SW, Chen HH, Tabar L., Day NE Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics in Medicine 1995 ; 14: 1531-1543.
11. Prevost TC, Launoy G., Duffy SW, Chen HH Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. American Journal of Epidemiology 1998 ; 148: 609-619.
12. World Health Organization. IARC handbooks of cancer prevention: handbook 7: breast cancer screening. IARC Press, Lyon, France; 2001.
13. Weedon-Fekjær H., Lindqvist BH, Vatten LJ, Aalen OO, Tretli S. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening. Journal of Medical Screening 2008 ; 15: 83-90.
14. Weedon-Fekjær H., Vatten LJ, Aalen OO, Lindqvist B., Tretli S. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening; new results. Journal of Medical Screening 2005 ; 12: 172-178.
15. Weedon-Fekjær H., Lindqvist B., Vatten LJ, Aalen OO, Tretli S. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Research 2008 ; 10: R41.
16. Shen Y., Zelen M. Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding. Biometrika 1999 ; 86: 503-515.
17. Cook RJ A mixed model for two-state Markov processes under panel observation. Biometrics 1999 ; 55: 915-920.
18. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine 2005 ; 353: 1784-1792.
19. CISNET Home Page. CISNET webpage. Available at: URL:http://cisnet.cancer. gov/ (accessed 2007 March 23).
20. Wang H., Kåresen R., Hervik A., Thoresen S. Mammography screening in Norway; results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control 2001 ; 1: 39-45.
21. Mammografiprogrammet (Norwegian Breast Cancer Screening Program). Available at: http://www.kreftregisteret.no/no/Forebyggende/ Mammografiprogrammet/ 2009.
22. Cancer Registry of Norway. Cancer in Norway 2006. http://www. kreftregisteretno 2007 Available from: URL: http://www.kreftregisteret.no (accessed 2007 January 25).
23. Hartveit F., Maehle BO, Pettersen KC Size of breast carcinomas at operation related to tumour growth rate. Breast Cancer Research Treatise 1987 ; 10: 47-50.
24. Moller B., Weedon-Fekjær H., Hakulinen T., et al. The influence of mammographic screening on national trends in breast cancer incidence. European Journal of Cancer Preview 2005 ; 14: 117-128.
25. Bakken K., Alsaker E., Eggen AE, Lund E. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. International Journal of Cancer 2004 ; 112: 130-134.
26. R core group. R. http://www r-project org 2003. Available at: URL: http://www.r-project.org (accessed 2006 September 11).
27. Weedon-Fekjær H. Modelling breast cancer incidence, progression and screening test sensitivity using screening data. University of Oslo, Norway; 2008.
28. Tabar L., Fagerberg G., Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995 ; 75: 2507-2517.
29. Paci E., Duffy SW Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). International Journal of Epidemiology 1991 ; 20: 852-858.